title: Hypercoagulability in Cushing's syndrome: the role of specific haemostatic and fibrinolytic markers.
abstract: OBJECTIVE
  Hypercoagulability is a commonly described complication in patients with Cushing's syndrome. Recent clinical studies have indicated various abnormalities of coagulation and fibrinolysis parameters which may be related to that phenomenon. The aim of this study was to investigate the mechanisms underlying the hypercoagulable state in patients with Cushing's syndrome.
  
  
  METHODS
  A wide range of serum markers involved in the processes of blood coagulation and fibrinolysis was measured in a group of 33 patients with Cushing's syndrome and 31 healthy controls. No participant was taking medication which could influence the result or had known diseases, except hypertension and diabetes, which could affect blood coagulation or fibrinolysis parameters.
  
  
  RESULTS
  Patients with Cushing's syndrome had higher levels of clotting factors II (P = 0.003), V (P < 0.001), VIII (P < 0.001), IX (P < 0.001), XI (P < 0.001) and XII (P = 0.019), protein C (P < 0.001), protein S (P < 0.001), C1-inhibitor (P < 0.001) and plasminogen activator inhibitor-1 (PAI-1) (P = 0.004). The activity of fibrinolytic markers, plasminogen (P < 0.001), antithrombin (P < 0.001) and antithrombin antigen (P = 0.001) was also increased in the patient group.
  
  
  CONCLUSIONS
  The study has demonstrated hypercoagulability in patients with Cushing's syndrome manifest as increased prothrombotic activity and compensatory activation of the fibrinolytic system. We propose the introduction of thromboprophylaxis in the preoperative and early postoperative periods, combined with a close follow-up in order to prevent possible thromboembolic events in patients with Cushing's syndrome.
authors.affiliation: Department of Internal Medicine, University Hospital Zagreb, Kispaticeva 12, 10000, Zagreb, Croatia. dkastelan@inet.hr
authors.forename: Darko
authors.initials: D
authors.lastname: Kastelan
authors.forename: Tina
authors.initials: T
authors.lastname: Dusek
authors.forename: Ivana
authors.initials: I
authors.lastname: Kraljevic
authors.forename: Ozren
authors.initials: O
authors.lastname: Polasek
authors.forename: Zlatko
authors.initials: Z
authors.lastname: Giljevic
authors.forename: Mirsala
authors.initials: M
authors.lastname: Solak
authors.forename: Silva Zupancic
authors.initials: SZ
authors.lastname: Salek
authors.forename: Jozo
authors.initials: J
authors.lastname: Jelcic
authors.forename: Izet
authors.initials: I
authors.lastname: Aganovic
authors.forename: Mirko
authors.initials: M
authors.lastname: Korsic
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D015415:Biomarkers / Q000097:blood*; D001779:Blood Coagulation Factors / Q000378:metabolism; D001780:Blood Coagulation Tests; D003480:Cushing Syndrome / Q000097:blood* / Q000150:complications*; D005342:Fibrinolysis / Q000502:physiology; D006487:Hemostasis / Q000502:physiology; D006801:Humans; D008875:Middle Aged; D019851:Thrombophilia / Q000097:blood* / Q000209:etiology*; D013927:Thrombosis / Q000097:blood / Q000209:etiology; D055815:Young Adult
chemical_list: D015415:Biomarkers; D001779:Blood Coagulation Factors